Edition:
United Kingdom

Strides Shasun Ltd (STSA.NS)

STSA.NS on National Stock Exchange of India

725.80INR
16 Feb 2018
Change (% chg)

-- (--)
Prev Close
Rs725.80
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
532,383
52-wk High
Rs1,212.45
52-wk Low
Rs641.95

Chart for

About

Strides Shasun Limited, formerly Strides Arcolab Limited, is a vertically integrated global pharmaceutical company. The Company is engaged in the development and manufacturing of active pharmaceutical ingredients (APIs) and formulations, as well as biotech. Its business segments include Pharmaceutical and Biotech businesses. Its... (more)

Overall

Beta: 0.59
Market Cap(Mil.): Rs74,972.77
Shares Outstanding(Mil.): 89.49
Dividend: 4.50
Yield (%): 0.54

Financials

  Industry Sector
P/E (TTM): -- 31.10 16.64
EPS (TTM): -- -- --
ROI: -- 14.90 10.66
ROE: -- 16.41 14.30

BRIEF-India's Strides Shasun Dec Qtr Consol Profit Down 56 Pct

* DEC QUARTER CONSOL PROFIT 825.9 MILLION RUPEES VERSUS PROFIT OF 1.87 BILLION RUPEES LAST YEAR

09 Feb 2018

BRIEF-Strides Shasun Says Co Not Participating In Process To Buy Orchid Chemicals & Pharmaceuticals

* CLARIFIES ON NEWS ITEM "BLACKSTONE, STRIDES, NECTAR LEAD RACE FOR ORCHID PHARMA"

05 Feb 2018

BRIEF-Strides Shasun Gets U.S. FDA Nod For Nystatin and Triamcinolone Acetonide Ointment

* SAYS GETS U.S. FDA APPROVAL FOR NYSTATIN AND TRIAMCINOLONE ACETONIDE OINTMENT Source text - http://bit.ly/2nnKyAr Further company coverage:

31 Jan 2018

BRIEF-Strides Shasun Gets U.S. FDA Approval For Piroxicam Capsules

* PRODUCT WILL BE MANUFACTURED AT CO'S ORAL DOSAGE FACILITY AT BANGALORE; WILL BE MARKETED BY STRIDES PHARMA IN U.S. MARKET Source text - http://bit.ly/2EqTVGU Further company coverage:

31 Jan 2018

BRIEF-Strides Shasun Gets U.S. FDA Nod For Tenofovir Disoproxil Fumarate Tablets

* GETS U.S. FDA NOD FOR TENOFOVIR DISOPROXIL FUMARATE TABLETS

29 Jan 2018

BRIEF-Sequent Scientific Gets Shareholders' Nod For Scheme Of Arrangement with Strides Shasun

* GETS SHAREHOLDERS' NOD TO APPROVE SCHEME OF ARRANGEMENT BETWEEN STRIDES SHASUN, CO AND SOLARA ACTIVE PHARMA SCIENCES Source text: (http://bit.ly/2DoTPO4) Further company coverage:

28 Dec 2017

BRIEF-Strides Shasun Gets Shareholders' Nod For Composite Scheme Of Arrangement With Sequent Scientific And Solara Active Pharma Sciences

* GETS SHAREHOLDERS' NOD FOR COMPOSITE SCHEME OF ARRANGEMENT BETWEEN CO, SEQUENT SCIENTIFIC AND SOLARA ACTIVE PHARMA SCIENCES Source text - http://bit.ly/2pNrrDh Further company coverage:

28 Dec 2017

BRIEF-Strides Shasun Acquires Controlling Stake In Trinity Pharma

* SAYS ACQUIRES CONTROLLING STAKE IN TRINITY PHARMA, SOUTH AFRICA

20 Dec 2017

BRIEF-Eris Lifesciences Says ‍Divestment Of Strides Shasun's India Brand Business To Co Completed

* SAYS ‍DIVESTMENT OF STRIDES SHASUN'S INDIA BRAND BUSINESS TO CO COMPLETED Source text - http://bit.ly/2kkCPEo Further company coverage:

04 Dec 2017

BRIEF-Strides Shasun gets U.S. FDA approval for acetazolamide tablets​

* Says product to be marketed by Strides Pharma Inc in the US market‍​ Source text for Eikon: Further company coverage:

22 Nov 2017

Earnings vs. Estimates